Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.

Identifieur interne : 000755 ( Main/Exploration ); précédent : 000754; suivant : 000756

Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.

Auteurs : Qinfang Liu [États-Unis] ; Laura C. Miller [États-Unis] ; Frank Blecha [États-Unis] ; Yongming Sang [États-Unis]

Source :

RBID : pubmed:28613152

Descripteurs français

English descriptors

Abstract

Type I interferons (IFNs) are critical in animal antiviral regulation. IFN-mediated signalling regulates hundreds of genes that are directly associated with antiviral, immune and other physiological responses. The signalling pathway mediated by mechanistic target of rapamycin (mTOR), a serine/threonine kinase regulated by IFNs, is key in regulation of cellular metabolism and was recently implicated in host antiviral responses. However, little is known about how animal type I IFN signalling coordinates immunometabolic reactions during antiviral defence. Here, using porcine reproductive and respiratory syndrome virus (PRRSV), we found that the genes in the mTOR signalling pathway were differently regulated in PRRSV-infected porcine alveolar macrophages at different activation statuses. Moreover, mTOR signalling regulated PRRSV infection in MARC-145 and primary porcine cells, in part, through modulating the production and signalling of type I IFNs. Taken together, we determined that the mTOR signalling pathway involves PRRSV infection and regulates expression and signalling of type I IFNs against viral infection. These findings suggest that the mTOR signalling pathway has a bi-directional loop with the type I IFN system and imply that some components in the mTOR signalling pathway can be utilized as targets for studying antiviral immunity and for designing therapeutic reagents.

DOI: 10.1099/jgv.0.000802
PubMed: 28613152
PubMed Central: PMC5962895


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.</title>
<author>
<name sortKey="Liu, Qinfang" sort="Liu, Qinfang" uniqKey="Liu Q" first="Qinfang" last="Liu">Qinfang Liu</name>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS</wicri:regionArea>
<placeName>
<region type="state">Kansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Miller, Laura C" sort="Miller, Laura C" uniqKey="Miller L" first="Laura C" last="Miller">Laura C. Miller</name>
<affiliation wicri:level="2">
<nlm:affiliation>USDA, Agricultural Research Service, National Animal Disease Center, Virus and Prion Research Unit, 1920 Dayton Avenue, Ames, IA 50010, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>USDA, Agricultural Research Service, National Animal Disease Center, Virus and Prion Research Unit, 1920 Dayton Avenue, Ames, IA 50010</wicri:regionArea>
<placeName>
<region type="state">Iowa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blecha, Frank" sort="Blecha, Frank" uniqKey="Blecha F" first="Frank" last="Blecha">Frank Blecha</name>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS</wicri:regionArea>
<placeName>
<region type="state">Kansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sang, Yongming" sort="Sang, Yongming" uniqKey="Sang Y" first="Yongming" last="Sang">Yongming Sang</name>
<affiliation wicri:level="2">
<nlm:affiliation>Present address: Department of Agricultural and Environmental Sciences, College of Agriculture, Human and Natural Sciences, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Present address: Department of Agricultural and Environmental Sciences, College of Agriculture, Human and Natural Sciences, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS</wicri:regionArea>
<placeName>
<region type="state">Kansas</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28613152</idno>
<idno type="pmid">28613152</idno>
<idno type="doi">10.1099/jgv.0.000802</idno>
<idno type="pmc">PMC5962895</idno>
<idno type="wicri:Area/Main/Corpus">000796</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000796</idno>
<idno type="wicri:Area/Main/Curation">000796</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000796</idno>
<idno type="wicri:Area/Main/Exploration">000796</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.</title>
<author>
<name sortKey="Liu, Qinfang" sort="Liu, Qinfang" uniqKey="Liu Q" first="Qinfang" last="Liu">Qinfang Liu</name>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS</wicri:regionArea>
<placeName>
<region type="state">Kansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Miller, Laura C" sort="Miller, Laura C" uniqKey="Miller L" first="Laura C" last="Miller">Laura C. Miller</name>
<affiliation wicri:level="2">
<nlm:affiliation>USDA, Agricultural Research Service, National Animal Disease Center, Virus and Prion Research Unit, 1920 Dayton Avenue, Ames, IA 50010, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>USDA, Agricultural Research Service, National Animal Disease Center, Virus and Prion Research Unit, 1920 Dayton Avenue, Ames, IA 50010</wicri:regionArea>
<placeName>
<region type="state">Iowa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blecha, Frank" sort="Blecha, Frank" uniqKey="Blecha F" first="Frank" last="Blecha">Frank Blecha</name>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS</wicri:regionArea>
<placeName>
<region type="state">Kansas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sang, Yongming" sort="Sang, Yongming" uniqKey="Sang Y" first="Yongming" last="Sang">Yongming Sang</name>
<affiliation wicri:level="2">
<nlm:affiliation>Present address: Department of Agricultural and Environmental Sciences, College of Agriculture, Human and Natural Sciences, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Present address: Department of Agricultural and Environmental Sciences, College of Agriculture, Human and Natural Sciences, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN</wicri:regionArea>
<placeName>
<region type="state">Tennessee</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS</wicri:regionArea>
<placeName>
<region type="state">Kansas</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of general virology</title>
<idno type="eISSN">1465-2099</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Cells, Cultured (MeSH)</term>
<term>Epithelial Cells (immunology)</term>
<term>Epithelial Cells (virology)</term>
<term>Host-Pathogen Interactions (MeSH)</term>
<term>Interferon Type I (metabolism)</term>
<term>Macrophages, Alveolar (immunology)</term>
<term>Macrophages, Alveolar (virology)</term>
<term>Porcine respiratory and reproductive syndrome virus (physiology)</term>
<term>Signal Transduction (MeSH)</term>
<term>Swine (MeSH)</term>
<term>TOR Serine-Threonine Kinases (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Cellules cultivées (MeSH)</term>
<term>Cellules épithéliales (immunologie)</term>
<term>Cellules épithéliales (virologie)</term>
<term>Interactions hôte-pathogène (MeSH)</term>
<term>Interféron de type I (métabolisme)</term>
<term>Macrophages alvéolaires (immunologie)</term>
<term>Macrophages alvéolaires (virologie)</term>
<term>Suidae (MeSH)</term>
<term>Sérine-thréonine kinases TOR (antagonistes et inhibiteurs)</term>
<term>Transduction du signal (MeSH)</term>
<term>Virus du syndrome respiratoire et reproducteur porcin (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Interferon Type I</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cellules épithéliales</term>
<term>Macrophages alvéolaires</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Epithelial Cells</term>
<term>Macrophages, Alveolar</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Interféron de type I</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virus du syndrome respiratoire et reproducteur porcin</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Porcine respiratory and reproductive syndrome virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Cellules épithéliales</term>
<term>Macrophages alvéolaires</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Epithelial Cells</term>
<term>Macrophages, Alveolar</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Host-Pathogen Interactions</term>
<term>Signal Transduction</term>
<term>Swine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules cultivées</term>
<term>Interactions hôte-pathogène</term>
<term>Suidae</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Type I interferons (IFNs) are critical in animal antiviral regulation. IFN-mediated signalling regulates hundreds of genes that are directly associated with antiviral, immune and other physiological responses. The signalling pathway mediated by mechanistic target of rapamycin (mTOR), a serine/threonine kinase regulated by IFNs, is key in regulation of cellular metabolism and was recently implicated in host antiviral responses. However, little is known about how animal type I IFN signalling coordinates immunometabolic reactions during antiviral defence. Here, using porcine reproductive and respiratory syndrome virus (PRRSV), we found that the genes in the mTOR signalling pathway were differently regulated in PRRSV-infected porcine alveolar macrophages at different activation statuses. Moreover, mTOR signalling regulated PRRSV infection in MARC-145 and primary porcine cells, in part, through modulating the production and signalling of type I IFNs. Taken together, we determined that the mTOR signalling pathway involves PRRSV infection and regulates expression and signalling of type I IFNs against viral infection. These findings suggest that the mTOR signalling pathway has a bi-directional loop with the type I IFN system and imply that some components in the mTOR signalling pathway can be utilized as targets for studying antiviral immunity and for designing therapeutic reagents.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28613152</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>07</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1465-2099</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>98</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2017</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of general virology</Title>
<ISOAbbreviation>J Gen Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.</ArticleTitle>
<Pagination>
<MedlinePgn>1316-1328</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1099/jgv.0.000802</ELocationID>
<Abstract>
<AbstractText>Type I interferons (IFNs) are critical in animal antiviral regulation. IFN-mediated signalling regulates hundreds of genes that are directly associated with antiviral, immune and other physiological responses. The signalling pathway mediated by mechanistic target of rapamycin (mTOR), a serine/threonine kinase regulated by IFNs, is key in regulation of cellular metabolism and was recently implicated in host antiviral responses. However, little is known about how animal type I IFN signalling coordinates immunometabolic reactions during antiviral defence. Here, using porcine reproductive and respiratory syndrome virus (PRRSV), we found that the genes in the mTOR signalling pathway were differently regulated in PRRSV-infected porcine alveolar macrophages at different activation statuses. Moreover, mTOR signalling regulated PRRSV infection in MARC-145 and primary porcine cells, in part, through modulating the production and signalling of type I IFNs. Taken together, we determined that the mTOR signalling pathway involves PRRSV infection and regulates expression and signalling of type I IFNs against viral infection. These findings suggest that the mTOR signalling pathway has a bi-directional loop with the type I IFN system and imply that some components in the mTOR signalling pathway can be utilized as targets for studying antiviral immunity and for designing therapeutic reagents.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Qinfang</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Laura C</ForeName>
<Initials>LC</Initials>
<AffiliationInfo>
<Affiliation>USDA, Agricultural Research Service, National Animal Disease Center, Virus and Prion Research Unit, 1920 Dayton Avenue, Ames, IA 50010, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Blecha</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sang</LastName>
<ForeName>Yongming</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Present address: Department of Agricultural and Environmental Sciences, College of Agriculture, Human and Natural Sciences, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Departments of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20 RR017686</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>06</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Gen Virol</MedlineTA>
<NlmUniqueID>0077340</NlmUniqueID>
<ISSNLinking>0022-1317</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016676" MajorTopicYN="N">Macrophages, Alveolar</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019316" MajorTopicYN="N">Porcine respiratory and reproductive syndrome virus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28613152</ArticleId>
<ArticleId IdType="doi">10.1099/jgv.0.000802</ArticleId>
<ArticleId IdType="pmc">PMC5962895</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Immunol. 2014 Jan;14(1):36-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24362405</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1997;142(12):2483-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9672608</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2007 Jul 13;282(28):20047-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17502369</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2012 Oct;8(10):1434-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22739997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2013 Aug;41(4):927-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23863158</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Res Immunol. 1998 Sep-Oct;149(7-8):685-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9851524</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2008 Oct;9(10):1157-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18758466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunology. 2007 Feb;120(2):217-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17116172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4808-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18339807</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2005 May;5(5):375-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15864272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Protoc. 2013 Nov;8(11):2281-2308</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24157548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Jul 24;10(7):e0133482</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26207988</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Feb 05;9(2):e87613</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24505295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2006 Apr 21;22(2):159-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16603397</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Immunol. 2015;33:257-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25581309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19812304</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Lett. 2014 Dec;8(6):2367-2370</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25360163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2015 Mar;36(3):124-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25704559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anim Health Res Rev. 2011 Dec;12(2):149-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22152291</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Virol. 2011 Dec;1(6):476-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22323926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2002 Jul 26;110(2):177-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12150926</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Genomics. 2010 Jul 7;42(2):248-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20406849</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Res Int. 2015;2015:394257</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25685786</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2012 Jan;4(1):102-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22355454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Jul 25;278(30):27772-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12759354</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Cell Biol. 2012 May;90(5):483-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22410872</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Rep. 2015 Apr 28;11(4):605-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25892232</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Oct;88(19):11395-410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25056886</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Anim Biosci. 2016;4:129-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26646630</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Immunol. 2015 Jan;36(1):21-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25592035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(8):e43418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22927967</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2015 Apr 16;202:101-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25529442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2008 Oct;9(10):1097-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18800159</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2015 Oct;15(10):599-614</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26403194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Cell Immunol. 2015 Apr;6(2):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26213635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Proc. 2011 Jun 03;5 Suppl 4:S8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21645323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2015 Sep 22;6(28):24586-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26309084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Nov 05;9(11):e112378</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25372927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2007 Jan 19;282(3):1757-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17114181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Immunol. 2014;32:513-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24555472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Biosci. 2008 Jan 01;13:453-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17981560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Rev. 2009 Jan;227(1):75-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19120477</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Biol. 2004 Jul 27;14(14):1296-302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15268862</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Biol. 2009 Feb 10;7(2):e38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19209957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1993 Aug;67(8):4760-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8392613</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Iowa</li>
<li>Kansas</li>
<li>Tennessee</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Kansas">
<name sortKey="Liu, Qinfang" sort="Liu, Qinfang" uniqKey="Liu Q" first="Qinfang" last="Liu">Qinfang Liu</name>
</region>
<name sortKey="Blecha, Frank" sort="Blecha, Frank" uniqKey="Blecha F" first="Frank" last="Blecha">Frank Blecha</name>
<name sortKey="Miller, Laura C" sort="Miller, Laura C" uniqKey="Miller L" first="Laura C" last="Miller">Laura C. Miller</name>
<name sortKey="Sang, Yongming" sort="Sang, Yongming" uniqKey="Sang Y" first="Yongming" last="Sang">Yongming Sang</name>
<name sortKey="Sang, Yongming" sort="Sang, Yongming" uniqKey="Sang Y" first="Yongming" last="Sang">Yongming Sang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000755 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000755 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28613152
   |texte=   Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28613152" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020